Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia

SUMMARY. In fetal alloimmune thrombocytopenia (FAIT) the fetus is threatened by intracranial haemorrhage (ICH); therefore early diagnostic and therapeutic intervention is required. We followed the clinical course of a 30‐year‐old woman during her fifth pregnancy after she had given birth to a child with alloimmune thrombocytopenia due to anti‐Zwa. The fetus was monitored by 13 fetal blood samplings (FBS) always followed by transfusion of either maternal or compatible donor platelets. Intravenous immunoglobulin (ivIg) treatment of the mother was begun at 20 weeks of gestation when the fetal platelet count was 36 times 109/1. The fetal platelets were typed Zwa positive by DNA analysis. Despite 11 weeks of maternal ivIg treatment fetal platelet counts progressively declined to 6 times 10/1 and ICH occurred. Subsequently, the fetus was successfully managed by intrauterine platelet transfusions at shorter intervals (3–5 days) and elective Cesarean section was carried out at 35 weeks of gestation. We conclude that maternal ivIg treatment does not prevent ICH in FAIT. The treatment of choice for severely affected cases is serial FBS combined with transfusion of compatible platelets.

[1]  T. Walsh,et al.  What Is the Optimal Storage Temperature for Whole Blood Prior to Preparation of Blood Components , 1993, Vox sanguinis.

[2]  C. Rodeck,et al.  Prenatal Management of Fetal Alloimmune Thrombocytopenia: Editorial , 1993 .

[3]  K. Nicolaides,et al.  Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. , 1993, Blood.

[4]  C. Harman,et al.  Intravenous fetal transfusion of immunoglobulin for alloimmune thrombocytopenia , 1992, The Lancet.

[5]  A. Huch,et al.  In-utero fetal therapy with immunoglobulin for alloimmune thrombocytopenia , 1992, The Lancet.

[6]  G. R. Cannell,et al.  The effect of intravenous immunoglobulin on placental transfer of a platelet‐specific antibody: Anti‐P1A1 , 1991, Transfusion medicine.

[7]  M. Morel-Kopp,et al.  HPA‐5b (Bra) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases , 1991, British journal of haematology.

[8]  J. Bussel,et al.  Recommendations for the Evaluation and Treatment of Neonatal Autoimmune and Alloimmune Thrombocytopenia , 1991, Thrombosis and Haemostasis.

[9]  J. Bussel,et al.  Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. , 1991, Blood.

[10]  C. Kaplan,et al.  Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia , 1990, The Lancet.

[11]  R. Berkowitz,et al.  Antenatal management of fetal alloimmune and autoimmune thrombocytopenia. , 1990, Transfusion medicine reviews.

[12]  K. Nicolaides,et al.  Management of Fetal Alloimmune Thrombocytopenia by Weekly in utero Platelet Transfusions , 1990, Vox sanguinis.

[13]  G. Mueller‐Eckhardt,et al.  348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIA , 1989, The Lancet.

[14]  C. Kaplan,et al.  Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. , 1989, Blood.

[15]  R. Berkowitz,et al.  Antenatal treatment of neonatal alloimmune thrombocytopenia. , 1988, The New England journal of medicine.

[16]  W. Künzel,et al.  PRENATAL TREATMENT OF FETAL ALLOIMMUNE THROMBOCYTOPENIA , 1988, The Lancet.

[17]  I. Kovar,et al.  Failure of Antenatal High‐Dose Immunoglobulin to Improve Fetal Platelet Count in Neonatal Allo‐Immune Thrombocytopenia , 1988, Vox sanguinis.

[18]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[19]  F. Daffos.  Technical aspects of prenatal samplings and fetal transfusion. , 1988, Current studies in hematology and blood transfusion.

[20]  V. Kiefel,et al.  Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. , 1987, Blood.

[21]  J. Muller,et al.  [Neonatal alloimmune thrombopenia. Clinical and biological study of 84 cases]. , 1985, Presse medicale.

[22]  G. T. Renner.  INTERNATIONAL FORUM , 1939 .